Boehringer Ingelheim Pharmaceuticals Inc. et al v. Hetero USA Inc. et al > Summary
Court Case Number 1:23-cv-00048
Filing Date Jan 13, 2023
Termination Date Oct 12, 2023
Court Delaware District Court
Status Dismissed - Settled
JudgesMichael A. Shipp, Colm F. Connolly
Defendant
Plaintiff Attorneys
12Boehringer Ingelheim International GmbH
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Brian P. Egan
Morris Nichols Arsht & Tunnell
Boehringer Ingelheim International GmbH
Attorney Name: Megan E. Dellinger
Morris Nichols Arsht & Tunnell
Defendant Attorneys
6Hetero
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Hetero
Attorney Name: Cortlan S. Hitch
Morris James LLP
Hetero
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Hetero
Attorney Name: Cortlan S. Hitch
Morris James LLP
Hetero
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Hetero
Attorney Name: Cortlan S. Hitch
Morris James LLP
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10034877 | Treatment for diabetes in patients inappropriate for metformin therapy | Jul 31, 2018 |
| 09486526 | Treatment for diabetes in patients inappropriate for metformin therapy | Nov 8, 2016 |
